Long et al. conducted a retrospective study analyzing overall survival (OS) in 746 non-metastatic BC patients, revealing that a lower albumin-to-alkaline phosphatase ratio (AAPR) was linked to a shorter OS25. QU et al. explored the predictive value of the AAPR for pCR in BC patients undergoing NACT. This evidence concerns the gene ALB and breast cancer.